Updated Date:
13 Dec 2024
Product Detail:
CYRAMZA ramucirumab 100 mg/10 mL solution for intravenous infusion vial
Shortage Status:
Discontinued
AUST R:
227351
Availability:
Reduction in supply until supply is exhausted
Active Ingredient:
ramucirumab
Reason:
Commercial Changes / Commercial viability
Dosage Form:
Injection,intravenousinfusion
Supply Impact Dates
Management Action:
Patients are advised to consult their healthcare professional to discuss alternative treatment options.
